Medicine recalls
|
| |
| Batch recall of Epiduo Forte 0.3%/2.5% Gel (15g) |
| |
The Department of Health (DH) today (Apr 12) endorsed a licensed drug wholesaler, Galderma Hong Kong Limited (Galderma), to recall one batch (batch number: 359448) of Epiduo Forte 0.3%/2.5% Gel, 15g bottle (Hong Kong registration number: HK-66483) from the market due to potential quality issue.
The DH received notification from Galderma that the overseas manufacturer of the product reported that, during stability testing, the assay of one of the active ingredients, benzoyl peroxide, in the above batch was found to be a bit higher than the labelled content, which may reflect a quality issue. As a precautionary measure, Galderma is voluntarily recalling the affected product from the market.
The above product, containing adapalene and benzoyl peroxide, is a prescription medicine used for the cutaneous treatment of acne vulgaris. According to Galderma, the affected batch has been supplied to private hospitals, private doctors and re-exported to Macau.
Galderma has set up a hotline (9545 6993) to answer related enquiries.
So far, the DH has not received any adverse reaction reports in connection with the affected batch of product. The DH will closely monitor the recall.
End/Wednesday, 12 April 2023
|
| |
